Inhibition or genetic manipulation that disrupts HDAC3-mediated delactylation leads to aggravated neuronal injury and larger infarct volumes, underscoring the enzyme’s importance in maintaining lactylation-mediated protective responses in the post-stroke brain (Sun et al., 2025). The gene discussed is HDAC3; the disease is stroke disorder.